Escola Superior de Ciências da Saúde, Universidade do Estado do Amazonas, Manaus, Brazil.
Diretoria de Ensino e Pesquisa, Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil.
PLoS Negl Trop Dis. 2024 Jan 19;18(1):e0011921. doi: 10.1371/journal.pntd.0011921. eCollection 2024 Jan.
Currently, antivenoms are the only specific treatment available for snakebite envenoming. In Brazil, over 30% of patients cannot access antivenom within its critical care window. Researchers have therefore proposed decentralizing to community health centers to decrease time-to-care and improve morbidity and mortality. Currently, there is no evidence-based method to evaluate the capacity of health units for antivenom treatment, nor what the absolute minimum supplies and staff are necessary for safe and effective antivenom administration and clinical management.
This study utilized a modified-Delphi approach to develop and validate a checklist to evaluate the minimum requirements for health units to adequately treat snakebite envenoming in the Amazon region of Brazil. The modified-Delphi approach consisted of four rounds: 1) iterative development of preliminary checklist by expert steering committee; 2) controlled feedback on preliminary checklist via expert judge survey; 3) two-phase nominal group technique with new expert judges to resolve pending items; and 4) checklist finalization and closing criteria by expert steering committee. The measure of agreement selected for this study was percent agreement defined a priori as ≥75%.
A valid, reliable, and feasible checklist was developed. The development process highlighted three key findings: (1) the definition of community health centers and its list of essential items by expert judges is consistent with the Brazilian Ministry of Health, WHO snakebite strategic plan, and a general snakebite capacity guideline in India (internal validity), (2) the list of essential items for antivenom administration and clinical management is feasible and aligns with the literature regarding clinical care (reliability), and (3) engagement of local experts is critical to developing and implementing an antivenom decentralization strategy (feasibility).
This study joins an international set of evidence advocating for decentralization, adding value in its definition of essential care items; identification of training needs across the care continuum; and demonstration of the validity, reliability, and feasibility provided by engaging local experts. Specific to Brazil, further added value comes in the potential use of the checklist for health unit accreditation as well as its applications to logistics and resource distribution. Future research priorities should apply this checklist to health units in the Amazon region of Brazil to determine which community health centers are or could be capable of receiving antivenom and translate this expert-driven checklist and approach to snakebite care in other settings or other diseases in low-resource settings.
目前,抗蛇毒血清是蛇伤中毒的唯一特效解毒药物。在巴西,超过 30%的患者无法在关键救治窗口内获得抗蛇毒血清。因此,研究人员提出将抗蛇毒血清治疗分散到社区卫生中心,以缩短救治时间,降低发病率和死亡率。目前,尚无循证医学方法来评估卫生单位的抗蛇毒血清治疗能力,也没有确定安全有效地使用抗蛇毒血清进行临床管理所需的绝对最低供应品和人员。
本研究采用改良 Delphi 法制定和验证了一份清单,用于评估巴西亚马逊地区卫生单位充分治疗蛇伤中毒的最低要求。改良 Delphi 法包括四轮:1)由专家指导委员会迭代制定初步清单;2)通过专家评委调查对初步清单进行控制反馈;3)利用新的专家评委进行两轮名义群体技术,以解决悬而未决的问题;4)由专家指导委员会完成清单定稿和结束标准。本研究选择的一致性衡量指标为预先定义的百分比一致性,即≥75%。
制定了一份有效、可靠且可行的清单。该开发过程突出了三个关键发现:1)专家评委对社区卫生中心的定义及其基本项目清单与巴西卫生部、世界卫生组织蛇伤战略计划和印度的一般蛇伤能力指南一致(内部有效性);2)抗蛇毒血清管理和临床管理的基本项目清单是可行的,并且与临床护理文献一致(可靠性);3)当地专家的参与对于制定和实施抗蛇毒血清分散策略至关重要(可行性)。
本研究加入了一组国际证据,主张分散抗蛇毒血清治疗,通过定义基本护理项目、确定整个护理连续体的培训需求以及展示当地专家参与提供的有效性、可靠性和可行性,增加了其价值。具体到巴西,该清单还可以用于卫生单位认证,以及物流和资源分配,进一步增加了其价值。未来的研究重点应将该清单应用于巴西亚马逊地区的卫生单位,以确定哪些社区卫生中心有能力或能够接收抗蛇毒血清,并将这种由专家驱动的清单和方法应用于其他环境或其他资源匮乏环境中的蛇伤护理。